Free Trial
NASDAQ:OPRX

OptimizeRx (OPRX) Stock Price, News & Analysis

OptimizeRx logo
$13.59 +0.09 (+0.67%)
Closing price 07/1/2025 04:00 PM Eastern
Extended Trading
$13.56 -0.04 (-0.26%)
As of 07/1/2025 05:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About OptimizeRx Stock (NASDAQ:OPRX)

Key Stats

Today's Range
$13.22
$13.69
50-Day Range
$8.38
$15.44
52-Week Range
$3.78
$15.71
Volume
197,070 shs
Average Volume
300,758 shs
Market Capitalization
$251.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.81
Consensus Rating
Moderate Buy

Company Overview

OptimizeRx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
32nd Percentile Overall Score

OPRX MarketRank™: 

OptimizeRx scored higher than 32% of companies evaluated by MarketBeat, and ranked 506th out of 665 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    OptimizeRx has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    OptimizeRx has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about OptimizeRx's stock forecast and price target.
  • Earnings Growth

    Earnings for OptimizeRx are expected to grow in the coming year, from ($0.33) to ($0.29) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of OptimizeRx is -16.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of OptimizeRx is -16.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    OptimizeRx has a PEG Ratio of 4.50. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    OptimizeRx has a P/B Ratio of 2.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about OptimizeRx's valuation and earnings.
  • Percentage of Shares Shorted

    9.37% of the float of OptimizeRx has been sold short.
  • Short Interest Ratio / Days to Cover

    OptimizeRx has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in OptimizeRx has recently increased by 1.95%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    OptimizeRx does not currently pay a dividend.

  • Dividend Growth

    OptimizeRx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.37% of the float of OptimizeRx has been sold short.
  • Short Interest Ratio / Days to Cover

    OptimizeRx has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in OptimizeRx has recently increased by 1.95%, indicating that investor sentiment is decreasing.
  • News Sentiment

    OptimizeRx has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for OptimizeRx this week, compared to 2 articles on an average week.
  • Search Interest

    15 people have searched for OPRX on MarketBeat in the last 30 days. This is an increase of 1,400% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added OptimizeRx to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, OptimizeRx insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.60% of the stock of OptimizeRx is held by insiders.

  • Percentage Held by Institutions

    76.47% of the stock of OptimizeRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about OptimizeRx's insider trading history.
Receive OPRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter.

OPRX Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Headlines

OPRX Stock Analysis - Frequently Asked Questions

OptimizeRx's stock was trading at $4.86 at the beginning of 2025. Since then, OPRX shares have increased by 179.6% and is now trading at $13.59.
View the best growth stocks for 2025 here
.

OptimizeRx Corp. (NASDAQ:OPRX) issued its quarterly earnings results on Monday, May, 12th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.19. The company had revenue of $21.93 million for the quarter, compared to the consensus estimate of $18.69 million. OptimizeRx had a negative trailing twelve-month return on equity of 0.29% and a negative net margin of 16.33%.
Read the conference call transcript
.

Shares of OPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that OptimizeRx investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Intel (INTC).

Company Calendar

Last Earnings
5/12/2025
Today
7/02/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
COMP - SOFTWARE
Sub-Industry
Business Services
Current Symbol
NASDAQ:OPRX
Employees
100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.81
High Stock Price Target
$16.00
Low Stock Price Target
$5.00
Potential Upside/Downside
-20.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
4.5
Net Income
-$18.66 million
Pretax Margin
-17.08%

Debt

Sales & Book Value

Annual Sales
$92.13 million
Price / Cash Flow
N/A
Book Value
$6.35 per share
Price / Book
2.14

Miscellaneous

Free Float
17,459,000
Market Cap
$251.42 million
Optionable
Optionable
Beta
1.34

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:OPRX) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners